like peptide-1 (GLP-1) elevates intracellular concentration of cAMP ([cAMP]) and facilitates glucose-dependent insulin secretion in pancreatic ␤-cells. There has been much evidence to suggest that multiple key players such as the GLP-1 receptor, Gs protein, adenylate cyclase (AC), phosphodiesterase (PDE), and intracellular Ca 2ϩ concentration ([Ca 2ϩ ]) are involved in the regulation of [cAMP]. However, because of complex interactions among these signaling factors, the kinetics of the reaction cascade as well as the activities of ACs and PDEs have not been determined in pancreatic ␤-cells. We have constructed a minimal mathematical model of GLP-1 receptor signal transduction based on experimental findings obtained mostly in ␤-cells and insulinoma cell lines. By fitting this theoretical reaction scheme to key experimental records of the GLP-1 response, the parameters determining individual reaction steps were estimated. The model reconstructed satisfactorily the dynamic changes in [cAMP] and predicted the activities of cAMP effectors, protein kinase A (PKA), and cAMPregulated guanine nucleotide exchange factor [cAMP-GEF or exchange protein directly activated by cAMP (Epac)] during GLP-1 stimulation. The simulations also predicted the presence of two sequential desensitization steps of the GLP1 receptor that occur with fast and very slow reaction rates. The cross talk between glucose-and GLP-1-dependent signal cascades for cAMP synthesis was well reconstructed by integrating the direct regulation of AC and PDE by [Ca 2ϩ ]. To examine robustness of the signaling system in controlling [cAMP], magnitudes of AC and PDE activities were compared in the presence or absence of GLP-1 and/or the PDE inhibitor IBMX. (55) and regulate pulsatile insulin release (25). This glucose-dependent insulin secretion is synergistically enhanced by incretin hormones, which are released upon meal ingestion from endocrine cells distributed over the intestinal tract (16). The incretin hormones include glucosedependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1). GLP-1 is more effective than GIP to improve deteriorated incretin effect in diabetes and is widely used to treat patients with Type 2 diabetes (45). Elucidation of GLP-1 signaling system in ␤-cells, therefore, has been an extensive target of experimental studies. To date, it has been well established that GLP-1 activates adenylate cyclases (ACs) through binding to its G protein-coupled receptor and increases
and regulate pulsatile insulin release (25) . This glucose-dependent insulin secretion is synergistically enhanced by incretin hormones, which are released upon meal ingestion from endocrine cells distributed over the intestinal tract (16) . The incretin hormones include glucosedependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1). GLP-1 is more effective than GIP to improve deteriorated incretin effect in diabetes and is widely used to treat patients with Type 2 diabetes (45) . Elucidation of GLP-1 signaling system in ␤-cells, therefore, has been an extensive target of experimental studies. To date, it has been well established that GLP-1 activates adenylate cyclases (ACs) through binding to its G protein-coupled receptor and increases [cAMP] , the key signal underlying the insulinotropic effects (17, 62) .
The [cAMP] is determined primarily by the balance between cAMP production by ACs and degradation by phospodiesterases (PDEs) (8) . The activities of several isoforms of AC and PDE expressed in ␤-cells are controlled by [Ca 2ϩ ] (11, 28) , which is regulated by Ca 2ϩ -permeable ion channels and transporters as well as Ca 2ϩ release and uptake by the endoplasmic reticulum (ER). The increase in [cAMP] subsequently activates protein kinase A (PKA) and exchange protein directly activated by cAMP (Epac), modulating the activities of multiple ion channels at the plasma membrane (26, 31, 35, 41, 42, 57) and ER (27, 36, 64) , which in turn modify the pattern of Ca 2ϩ transients. PKA and Epac also have direct effects on proteins that are involved in exocytosis of insulin vesicles (30) , and thus the fine regulation of [cAMP] is critical for the adequate insulinotropic effects of GLP-1. However, since multiple signaling factors are involved in regulating [cAMP] , the kinetic aspects of the reaction cascade during GLP-1 stimulation have not yet been determined in pancreatic ␤-cells.
To overcome this difficulty, we developed a mathematical model of GLP-1 receptor signal transduction. We adopted a strategy of estimating individual reaction rates and model parameters by fitting the theoretical reaction scheme to a variety of key experimental findings published to date (3, 11, 54, 66) in both ␤-cells and insulinoma cell lines. The model thus developed was validated by reconstructing the dynamic changes in [cAMP] during GLP-1 stimulation in the presence and absence of 3-isobutyl-1-methylxanthine (IBMX) observed under various experimental conditions. The model well-simulated GLP-1-induced [cAMP] elevation and predicted the activities of cAMP effectors PKA and Epac as a function of GLP-1. The simulation analysis revealed the presence of two transition steps of receptor desensitization that occur with fast and slow kinetics. The molecular basis for synergistic relationship between glucose and GLP-1 signaling in the cAMP synthesis were clarified by calculating the direct regulation of AC and PDE by [Ca 2ϩ ]. Finally, the robustness of the signaling system in controlling [cAMP] was examined by comparing the AC and PDE activities in the presence or absence of GLP-1 and/or the PDE inhibitor.
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METHODS
A minimal model of the GLP-1 receptor signaling transduction in pancreatic ␤-cells was constructed. Parameters to define the model, including concentrations, binding constants (K d) of signaling factors, maximum activity (Vmax) and half-maximal effective concentration (K1/2) of substances for activation of enzymes, rate constants, and various magnitude factors of kinetic equations are listed in APPENDIX I. The time-based integration of six differential equations (Eqs. [3] [4] [5] [6] [7] [8] were performed using the Euler method with a time step of Ͻ2 ms on the Microsoft Visual Studio platform. The units of time and substrate concentrations are secons and millimolar (indicated otherwise), respectively.
Activation of GLP-1 receptor. Figure 1 shows the reaction scheme of the minimal model of the GLP-1 receptor cascade. Active receptors may form three different conformations: free receptor (R), ligand (L)-bound receptor (LR), and the Gs-bound LR complex (LRG). Binding reactions indicated by black arrows were assumed to be much faster than the rest of reactions associated with conformational changes (22) , and thus an instantaneous equilibrium was assumed for the reactions enclosed within the red rectangle. The dissociation constant (K d) for GLP-1 binding to the receptor has been determined in expression systems (43, 65) , whereas Kd for LR and G was estimated by fitting the [GLP-1]-dependent [cAMP] accumulation (66) . In calculating the reaction cascade, total amounts [R t] and [Gt] were conserved by applying Eqs. 1 and 2, respectively.
(1)
Upon ligand binding, the GLP-1 receptor undergoes desensitization through phosphorylation by unknown mechanisms (67) . Although the molecular mechanism has not been elucidated, the computer simulation of the spontaneous decay in [cAMP] during continuous stimulation with GLP-1 (see Fig. 3 ) as well as desensitized [cAMP] production after preconditioning of GLP-1 receptors (see Fig. 4 ) suggested the presence of two sequential desensitization states R D1 and RD2. We assume that the first desensitization step to RD1 occurs from the ligand-bound form of the receptor, (LR ϩ LRG), followed by the second transition to RD2 with a recovery steps to Ra (see Fig. 1 ). The rate constants for the timedependent desensitization were determined by fitting the kinetic sheme to experimental recordings, and the time-dependent changes in [R D1] and [RD2] are defined with Eqs. 3 and 4, respectively.
The kinetics for the activation and deactivation of G protein are calculated by rate constants of G dissociation into G␣GTP and G␤␥ subunits and subsequent hydrolysis of GTP (APPENDIX I), which have been biochemically investigated (5, 56 
AC and PDE activities. The level of [cAMP] is determined by the balance between production rate (VAC_t) and degradation rate (VPDE) by ACs and PDEs, respectively (Eq. 8).
At least nine different isoforms of membrane-bound AC have been identified (29) . In pancreatic ␤-cells, ACVIII was suggested to play a predominant role in synthesis of cAMP during GLP-1 stimulation of ␤-cells (53) . The modulation of ACVIII by both Ca 2ϩ -bound calmodulin (CaxCaM) and Gs␣GTP would provide the molecular basis for synergistic relationship between glucose and GLP-1 stimulation in the cAMP synthesis (11) . In addition to this adaptable component Fig. 1 . Reaction scheme of glucagon-like peptide-1 (GLP-1) receptor activation. The receptor takes five different conformations: R, free receptor; LR, ligand (L)-bound form; LRG, Gs-bound LR complex; RD1, desensitized receptor at the state D1 with faster kinetics defined by rate constants k1 and k2; and RD2, desensitized receptor at the state D2 with the very slow kinetics defined by rate constants k3 and k4. The desensitization to RD1 occurs only from the ligand bound form (LR and LRG) with k1, and the recovery to active receptos (Ra) (ϭ R ϩ LR ϩ LRG) with k2. States of Gs protein include G␣␤␥, heterotrimeric complex (for [G] and [LRG] ) and dissociated subunits G␣GTP, G␣GDP, and G␤␥. Time-dependent changes in conformations of G protein are calculated by rate constants of Gs dissociation into G␣GTP and G␤␥ subunits (k5), subsequent hydrolysis of GTP (k6), and reassociation of G␣GDP with G␤␥ (k7). The reaction steps marked with a black arrow were calculated assuming instantaneous equilibrium, whereas those marked with blue arrows were calculated by the time-based integration using the Euler method. When calculating the instantaneous equilibrium enclosed with the red rectangle, the constraint of mass conservation was applied to the sum of (R ϩ LR ϩ LRG) and (G ϩ LRG), respectively, at each time step.
(VAC_G), a basal component (VAC) was assumed to maintain the resting [cAMP] in the absence of agonists. Thus the total activity of ACs (VAC_t) is given by a sum of VAC and VAC_G (Eqs. 9 -11).
[ATP] ϩ 1.03 (10)
[ATP] ϩ 0.315 (18, 33, 60 ). An instantaneous equilibrium was assumed for the binding of Ca 2ϩ to CaM using the association and dissociation rate constants given by Yu and colleagues (69) . The VAC_t was determined at 1.8 M/s from the initial rate of rise (dashed line in In ␤-cells, it has been suggested that several PDE isoforms (1C, 3B, 4, 8B, and 10A) are involved in regulation of insulin secretion (15, 51) . However, the fractional contribution of each isoform to cAMP degradation in intact cells has not yet been determined. Sams and Montague (54) observed over 70% of total PDE activity in the supernatant fraction of an homogenate of islets of Langerhans. Their kinetic analysis of the soluble PDEs suggested the presence of at least two fractions with different activities, as indicated by two linear components (dashed and solid black lines) in the Lineweaver-Burk plot (Fig. 2) . We reevaluated the experimental results by fitting the data with a sum of two Michaelis-Menten functions (Eq. 12) in the present study.
The fitting (gray curve in Fig. 2 ) determined the K m values (KmL and KmH) and f of the two components. VPDE thus reflects the sum of all PDE activities.
Since Ca xCaM-sensitive PDE1C plays a functional role in degradation of cAMP in the ␤-cell lines ␤TC3 (28) and MIN6 (38), a Ca 2ϩ -dependent component was added to the PDE model (Eq. 13).
The half-maximal value of CaxCaM for the stimulation of PDE (68) was adopted from the PDE model developed for ␤-cells (23) , and fCd_PDE reflects the fraction of the CaxCaM-dependent component of the enzyme. Given the [cAMP]s determined under various experimental conditions (Table 1) , Vmax_PDE and fCd_PDE (APPENDIX I) were finely adjusted by reconstructing these experimental findings using 100 or 500 nM [Ca 2ϩ ] according to the [glucose] used in experiments. In experimental studies, the rise in Fig. 3A ). The velocity of cAMP degradation by PDE gradually increases with increasing [cAMP] , and the peak is attained when the production rate of cAMP (V AC_t ) matched the degradation rate by PDE (V PDE in Eq. 8). Simulations revealed that the time to peak as well as the subsequent slow decline in [cAMP] were also influenced by desensitization of the GLP-1 receptor, predominantly due to the state transition to R D1 (Fig. 1) . In the absence of IBMX, the balance between AC and PDE activities are attained at a much lower [cAMP], thereby giving a time to peak of Ͻ1 min (gray curve, Fig. 3A ). The simulation result was also in good agreement with experimental data (open circles, Fig. 3A) .
The experimental dose-response relationship obtained by Widmann and colleagues (66) was reconstructed by calculating the [cAMP] accumulation attained over 10 min application of different concentrations of GLP-1 at 20% PDE activity and 500 nM [Ca 2ϩ ] (Fig. 3, B and C Ultra-slow desensitization of the GLP-1 receptor. The simulation analysis suggested that the gradual decay of [cAMP] after the peak (Fig. 3, A and B) during GLP-1 stimulation largely reflects desensitization of the ligand-bound receptor (LR and LRG in Fig. 1 ) to R D1 . However, the R D1 kinetics alone failed to reconstruct the very slow inactivation remaining 1 h after washing out agonist as observed by Baggio and colleagues (3). The model including an R D2 state in series with R D1 reconstructed well the desensitization phenomenon in response to the experimental protocol (Fig. 4A) . When the 2-h prestimulation protocol was applied (Fig. 4B) , the R D1 fraction (blue curve) increased to a maximum of ϳ0.28 at the expense of the active fraction (R a , red curve) within the initial 10 min, and then both R a and R D1 slowly declined thereafter due to a continuous transition to R D2 (green curve). During the washout period, the R D1 fraction quickly became insignificant, whereas 85% of R D2 remained even after 1 h washout. The result suggests that the fraction of R a available for the second application of GLP-1 decreases depending on the preincubation period. Figure 4C shows the [cAMP] response to the experimental protocol with varying pretreatment periods. It is evident, as predicted, that the longer the preincubation period, the more the [cAMP] response was reduced on the second application of GLP-1. The reductions (in %) in [cAMP] accumulations on the second stimulus were normalized to the control amplitude and were summarized in Table 2 . These results agreed well with the experimental observations (3).
To characterize the steady-state desensitization of the GLP-1 receptor, the [GLP-1]-dependent V AC_t at varying incubation periods (10 s ϳ 4,000 min) were computed over the range 0.001ϳ100 nM [GLP-1] (Fig. 4D) . With 6-and 10-s applications, V AC_t nearly overlap one another virtually without any sign of receptor desensitization. When the duration of GLP-1 application was prolonged, the desensitization gradually developed and a steady state was obtained at ϳ2,000 min application, which gave ϳ25% of the control V AC_t at the saturating , and 4,000 min, from top to bottom of 8 curves, respectively. The traces of 6 and 10 s stimulation almost overlapped with one another, indicating that the desensitization was invisible with these short periods, whereas traces with 2,000 and 4,000 min stimulation also overlapped, indicating saturation of the desensitization already at ϳ2,000 min. ] was out of phase without agonist (19, 23, 38) . The simulation in Fig. 5 (19) . The fluorescent signals were detected using evanescent wave microscopy reflecting [cAMP] in the submembrane space. However, since the signals were not calibrated, extent of PKA activation by the GLP-1 stimulus was not obtained from the experimental results. We thus attempted to predict PKA activity using the GLP-1 receptor signal cascade model developed in the present study (Fig. 6) . Toward this end, it was essential to examine the localization of cAMP under the surface membrane compared with the bulk [cAMP], since the PKA activities may vary within the cytosol due to an uneven distribution of cAMP. In pancreatic ␤-cells, highly localized cAMP microdomain may possibly be present at submembrane space, since production of cAMP by ACs is limited at the surface membrane (29, 38) , while PDE-mediated degradation occurs diffusely within the cytosol (4, 54) . Indeed, cAMP microdomain has been observed beneath the surface membrane in other cell types, such as cardiac myocytes (70) and HEK cells (61) .
To simulate the distribution of [cAMP], intracellular diffusion of cAMP was calculated (Fig. 7) . For simplicity, one-dimensional diffusion was assumed over a distance of 4 m (estimated from Ref. 48 ) from the surface membrane toward the nucleus as indicated in Fig. 7A . The diffusion path (x) was separated into 200 compartments, and [cAMP] in each compartment at time t [C (x,t)] was calculated using the following equation: ] condition were simulated (Fig. 6A) . The [cAMP]-dependent PKA activation was calculated using a Fig. 6A , the active fractions of Epac1 and 2, other cAMP effectors, were also simulated using the half-maximal values of cAMP for the activation of each enzyme (APPENDIX I). GLP-1 at 100 nM activates Epac1 from 4.4% of basal activity to 15.3%, whereas active Epac2 was about 6.4% at rest and was increased to ϳ21.3% (Fig. 6B) .
Systems analysis on the balance between the production and degradation of cAMP. The level of [cAMP] is determined by the balance between AC and PDE activities (Eq. 2 ϭ ϳ3 M) . This analysis revealed that the intact PDE is highly capable of balancing V AC_t , and thus we conclude that the system of [cAMP] regulation is quite robust in pancreatic ␤-cells. The delayed desensitization of the GLP-1 receptor (Fig. 4D) may further strengthen the robustness of the system.
DISCUSSION
In the present study, a minimal model of GLP-1 receptor signal transduction was developed mostly based on experimental data reported in ␤-cells or related cell lines. The model successfully reconstructed the experimental findings of dynamic changes in [cAMP] during agonist stimulation in the absence or presence of IBMX at two representative levels of [Ca 2ϩ ] (Fig. 3) . The model predicted the activity of cAMP effectors PKA and Epac during GLP-1 stimulation (Fig. 6) . The simulation also demonstrated that the GLP-1 receptor desensitization kinetics applied to the model successfully explained the fast and very slow inactivation steps, which have significant effects on the decay kinetics of [cAMP] during continuous GLP-1 stimulation (Fig. 3) as well as reduced [cAMP] production after preconditioning of the receptor (Fig.  4 and Table 2 ). The cross talk between glucose-and GLP-1-dependent signal cascades in synergistic synthesis of cAMP was well reconstructed by incorporating the direct regulation of both AC and PDE by [Ca 2ϩ ] ( Table 1) . Models of the [Ca 2ϩ ]-dependent AC and PDE activities also elucidated the fractions of [Ca 2ϩ ]-sensitive components of these enzymes. Considering that [Ca 2ϩ ] is raised by [glucose] stimulation via the enhanced electrical activity of ␤-cells, the activation of GLP-1 signaling is a powerful amplifier for promoting the insulin release in the presence of stimulating concentrations of glucose.
The insulinotropic effect of the cAMP signal involves the activation of PKA and Epac, and subsequent modulation of ion channel functions (26, 31, 35, 41, 42, 57) and Ca 2ϩ release from ER (27, 36, 64) , in addition to their direct effects on the exocytotic machinery. The effects on ion channels, for example, include the enhancement of Ca 2ϩ influx via L-type Ca 2ϩ currents (26, 57) and inhibition of K ϩ currents (26, 31, 35, 41, 42) , which may in turn promote the insulin release via an increase in the membrane excitability. These comprehensive mechanisms of the insulinotropic effect of GLP-1 will be analyzed by incorporating the GLP-1 receptor signaling cascade model into appropriate whole ␤-cell models (24, 44) in the future.
In the present study, the distribution of [cAMP] within the cytosol of pancreatic ␤-cells was estimated (Fig. 7) . It was suggested that the localization of cAMP beneath the surface membrane is insignificant even though production of cAMP is limited at the submembrane space, while PDE-mediated degradation occurs diffusely within the cytosol. Our finding is, however, different from the localized cAMP microdomain observed in other cell types [cardiac myocytes (70) and HEK293 cells (61) ]. The theoretical study by Oliveira et al. (47) demonstrated a large [cAMP] gradient (ϳ5 M) in HEK293 cells upon stimulation with PGE1. They concluded that the PDE4D activity enhanced by PKA-mediated phosphorylation was necessary and sufficient for generating the cAMP microdomain observed by Terrin et al. (61) , and no physical barrier was required against the cAMP diffusion. If compared with our simulation, the cAMP diffusion constant used in their study was essentially the same magnitude as in our calculations. Interestingly, our diffusion model also generated a similar [cAMP] gradient of ϳ4 M (Fig. 7C) when simulated using the V PDE equivalent to that used in the Oliveira et al. (47) . However, their V PDE was much higher (ϳ100 hold) than that determined by the model fitting to the published experimental data in the present study. If we adopt the higher PDE activity, the model failed to reconstruct experimental records of [cAMP] changes during GLP-1 stimulation. Our simulation results strongly suggest that the distribution of cAMP is homogeneous in pancreatic ␤-cells because of relatively low PDE activities. These results, however, do not necessarily exclude the possibility of a functional coupling among AC, PKA, and/or Epac and effecter proteins by AKAP near the membrane, which has been suggested in the heart and brain (12, 46) . On the other hand, the rapid diffusion of [cAMP] could possibly be an essential factor in the GLP-1 receptor signaling for a proper modulation of insulin release, since PKA and Epac, the target proteins of cAMP, are widely distributed throughout the intracellular space (12, 40, 49) . For activation of all these enzymes, the rapid access of cAMP might be critical to fulfill the basic needs of subsequent modulatory actions on ion channels on the surface and ER membrane as well as exocytotic machinery in concert within the entire intracellular space.
Sensitivity of the model to varying parameters. Athough [R] was estimated in a previous study (66) , [G] has not yet been determined in pancreatic ␤-cells. In the present study, [G] Fig. 4D ), which is expected to proceed during several hours of the meal digestion.
The maximum AC activity (V max_AC_t ϭ V max_AC ϩ V max_AC_G ) is much larger than the V max of PDE in our model. Limitations. The kinetics of the simple sequential transition of desensitized receptors from R D1 to R D2 was modeled to describe the time course of the delayed recovery from slow inactivation (Fig. 4) . Indeed, the reaction scheme for receptor desensitization ( Fig. 1) well simulated both of the fast and very slow desensitization observed in experimental studies (see RESULTS). Up to date, it is clear that the phosphorylation of the GLP-1 receptor is the key desensitization step, whereas Widmann and colleagues (67) have shown that neither PKA nor PKC are involved in the process. The involvement of ␤-Arrestin2 and GRK5 was suggested by Jorgensen et al. (34) , whereas it is still highly controversial since a different group demonstrated the desensitization was independent of ␤-Arrestin2 (59). The model scheme will need to be improved when the molecular mechanisms are established in future experimental studies. It may also be examined whether the activation of PDE through phosphorylation by PKA is responsible for a small fraction of the spontaneous decay of [cAMP] , although the present study attributed the decay only to desensitization.
The active fractions of PKA as well as Epac1 and 2 were calculated by a use of biochemically determined K d or K 1/2 , half-maximal [cAMP] for the activation of these enzymes. However, especially for PKA activation, there has been obvious disagreement in published values of K 1/2 , which vary over a nanomolar to micromolar range. It seems that the experimental K 1/2 is highly related to the concentration of enzyme used in biochemical investigations (7) . K 1/2 was ϳ3 M for more physiological concentration of the PKA isozyme II (400 nM), whereas it was significantly reduced to ϳ50 nM when tested on 1 nM holoenzyme. Indeed, other investigators (14) used low holoenzyme concentrations of 20ϳ30 nM and obtained a K 1/2 of 98 nM and 540 nM for PKAI and PKAII, respectively. In the present study, PKA activities were calculated with K 1/2 of ϳ3 M, yet, it may need to be reevaluated when more accurate experimental measurements of K 1/2 values as well as concentrations of PKA isozyme become available.
cAMP is distributed within a ␤-cell in forms of free cAMP and PKA or Epac-bound form (cAMP-PKA and cAMP-Epac). In the present study, however, [ 
C) Parameters Determined in the Present Study by Fitting the Overall Model Scheme to Experimental Records or Measurements In References
Binding between ͓G͔ and ͓LR͔ K d ϭ 0.372 M ͑Ref. 66͒
